BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11345026)

  • 1. Results of Ukrain monotherapy of prostate cancer.
    Uglyanitsa KN; Nechiporenko NA; Nefyodov LI; Doroshenko YM; Brzosko W; Nowicky W
    Drugs Exp Clin Res; 2000; 26(5-6):191-3. PubMed ID: 11345026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain.
    Uglyanitsa KN; Nefyodov LI; Karayedova LM; Nowicky JW; Brzosko W
    Drugs Exp Clin Res; 2000; 26(5-6):239-47. PubMed ID: 11345031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ukrain treatment of a patient with retroperitoneal synovial sarcoma. Case report.
    Prokopchuk OL; Zemskov SV; Susak YM
    Drugs Exp Clin Res; 2000; 26(5-6):255-6. PubMed ID: 11345034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of different doses of Ukrain in the combined treatment of breast cancer.
    Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Brzosko WJ
    Drugs Exp Clin Res; 2000; 26(5-6):201-21. PubMed ID: 11345028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ukrain both as an anti cancer and immunoregulatory agent.
    Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
    Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid alkaloid derivatives from Chelidonium majus L. (Ukrain).
    Staniszewski A; Slesak B; Kołodziej J; Harłozińska-Szmyrka A; Nowicky JW
    Drugs Exp Clin Res; 1992; 18 Suppl():63-7. PubMed ID: 1305047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ukrain (NSC-631570) in the treatment of pancreas cancer.
    Zemskov VS; Procopchuk OL; Susak YM; Zemskov SV; Hodysh YY; Zemskova MV
    Drugs Exp Clin Res; 2000; 26(5-6):179-90. PubMed ID: 11345025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky.
    Pengsaa P; Wongpratoom W; Vatanasapt V; Udomthavornsuk B; Mairieng E; Tangvorapongchai V; Pesi M; Krusan S; Boonvisoot V; Nowicky JW
    Drugs Exp Clin Res; 1992; 18 Suppl():69-72. PubMed ID: 1305048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. Report 1. Clinical aspects of Ukrain application.
    Uglyanitsa KN; Nefyodov LI; Brzosko V
    Drugs Exp Clin Res; 2000; 26(5-6):223-30. PubMed ID: 11345029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies of Ukrain in terminal cancer patients (phase II).
    Musianowycz J; Judmajer F; Manfreda D; Spängler P; Albrecht H; Hoffmann J; Meijer D
    Drugs Exp Clin Res; 1992; 18 Suppl():45-50. PubMed ID: 1305043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors.
    Aschhoff B
    Drugs Exp Clin Res; 2000; 26(5-6):249-52. PubMed ID: 11345032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ukrain therapy of stage T1N0M0 bladder cancer patients.
    Uglianitsa KN; Nechiporenko NA; Nefyodov LI; Brzosko WJ
    Drugs Exp Clin Res; 1998; 24(5-6):227-30. PubMed ID: 10190079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ukrain treatment in a patient with metastatic renal cell carcinoma extending to the vena cava inferior. Case report.
    Prokopchuk OL; Zemskov SV; Susak YM
    Drugs Exp Clin Res; 2000; 26(5-6):257-9. PubMed ID: 11345035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma.
    Voltchek IV; Liepins A; Nowicky JW; Brzosko WJ
    Drugs Exp Clin Res; 1996; 22(3-5):283-6. PubMed ID: 8899349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. ("Ukrain") as an immunostimulant in patients with various carcinomas.
    Nowicky JW; Staniszewski A; Zbroja-Sontag W; Slesak B; Nowicky W; Hiesmayr W
    Drugs Exp Clin Res; 1991; 17(2):139-43. PubMed ID: 1713821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies of breast cancer with the antitumor drug Ukrain.
    Nefyodov LI; Uglyanitsa KN; Smirnov VY; Karavay AV; Brzosko W
    Drugs Exp Clin Res; 2000; 26(5-6):231-7. PubMed ID: 11345030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ukrain treatment in a patient with breast carcinoma. Case report.
    Zemskov SV; Prokopchuk OL; Susak YM
    Drugs Exp Clin Res; 2000; 26(5-6):253-4. PubMed ID: 11345033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Ukrain on patients with surgically treated breast cancer. Part III. The immune system.
    Fomin KA; Uglyanica KN; Nefyodov LI; Djurd TI; Nowicky JW; Brzosko WJ; Jankowski A
    Drugs Exp Clin Res; 1996; 22(3-5):143-5. PubMed ID: 8899318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the complex treatment of rectal cancer patients (chemotherapy and X-ray therapy, Ukrain monotherapy).
    Bondar GV; Borota AV; Yakovets YI; Zolotukhin SE
    Drugs Exp Clin Res; 1998; 24(5-6):221-6. PubMed ID: 10190078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy of Ukrain in the treatment of breast cancer: clinical and laboratory studies.
    Uglianitsa KN; Nefyodov LI; Brzosko W
    Drugs Exp Clin Res; 1998; 24(5-6):231-9. PubMed ID: 10190080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.